BU
XBI icon

BBVA USA’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BBVA USA’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$94K Hold
750
– – 0.01% 551
2021
Q2 		$102K Buy
+750
New +$98.6K 0.01% 558

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BBVA USA's XBI Position: Q3 2021 in Review

BBVA USA held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2021 at 750 shares worth $94K. The position accounts for 0.01% of the portfolio, ranked #551.

BBVA USA first reported a position in XBI in Q2 2021 and has held it in 2 quarters since. The position peaked at $102K in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

  • BBVA USA held 750 shares of State Street SPDR S&P Biotech ETF worth $94K as of Q3 2021.
  • BBVA USA left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2021.
  • State Street SPDR S&P Biotech ETF made up 0.01% of BBVA USA's portfolio in Q3 2021, its #551 holding.
  • BBVA USA first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's State Street SPDR S&P Biotech ETF position peaked at $102K in Q2 2021.
  • 635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.